1. The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
- Author
-
Liao, Yen-Nung, Hu, Wen-Long, Chen, Hsuan-Ju, and Hung, Yu-Chiang
- Subjects
- *
AGE distribution , *ALTERNATIVE medicine , *ASTHMA , *BRONCHITIS , *CHI-squared test , *CHRONIC diseases , *CONFIDENCE intervals , *DATABASES , *DRUG prescribing , *EPIDEMIOLOGICAL research , *HERBAL medicine , *HEALTH insurance , *LONGITUDINAL method , *OBSTRUCTIVE lung diseases , *CHINESE medicine , *NOSOLOGY , *OCCUPATIONS , *POPULATION geography , *PROBABILITY theory , *RESEARCH funding , *STATISTICAL sampling , *SEX distribution , *STATISTICAL hypothesis testing , *T-test (Statistics) , *PHYSICIAN practice patterns , *MULTIPLE regression analysis , *CROSS-sectional method , *DATA analysis software , *DESCRIPTIVE statistics , *ODDS ratio - Abstract
In Oriental countries, combinations of Chinese herbal products (CHPs) are often utilized as therapeutic agents for chronic obstructive pulmonary disease (COPD). The effects of CHPs on COPD have been previously reported. This study aimed to analyze the frequency of prescription and usage of CHPs in patients with COPD in Taiwan. In this nationwide population-based cross-sectional study, 19,142 patients from a random sample of one million individuals in the Longitudinal Health Insurance Database 2000 (LHID 2000) of the National Health Insurance Research Database (NHIRD) were enrolled from 2000 to 2011. The multiple logistic regression method was used to evaluate the adjusted odds ratios for the utilization of CHPs. For patients with COPD, there was an average of 6.31 CHPs in a single prescription. The most frequently prescribed CHP for COPD was Xiao-Qing-Long-Tang (XQLT) (2.6%), and the most commonly used combination of two formula CHPs was XQLT with Ma-Xing-Gan-Shi-Tang (MXGST) (1.28%). The most commonly used single CHP for COPD was Bulbus Fritillariae (3.65%), and the most commonly used combination of two single CHPs was Bulbus Fritillariae with Puerariae Lobatae (1.09%). These results provide information regarding personalized therapies and may promote further clinical experiments and pharmacologic research on the use of CHPs for the management of COPD. Furthermore, we found that TCM usage was more prevalent among men, younger, manual workers, residents of Northern Taiwan, and patients with chronic bronchitis and asthma. This information on the distribution of TCM usage around the country is valuable to public health policymakers and clinicians. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF